149 related articles for article (PubMed ID: 5781333)
1. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
[No Abstract] [Full Text] [Related]
2. [Clinical study of a new anti-ulcer drug: CR-242, Xylamide, in 23 cases].
Uzeta Mejia S
Minerva Med; 1969 Mar; 60(23):1070-3. PubMed ID: 5781335
[No Abstract] [Full Text] [Related]
3. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
Linati E
Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
[No Abstract] [Full Text] [Related]
4. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
Bianchi PG; Saccabusi E
Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
[No Abstract] [Full Text] [Related]
5. [Study of gastric secretory function and its inhibition with Xylamide. The maximal acid output (MAO) test and the Hollander test].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1063-9. PubMed ID: 5781334
[No Abstract] [Full Text] [Related]
6. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
Borellini D; Milvio C
Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
[No Abstract] [Full Text] [Related]
7. [Evaluation of the therapeutic activity of CR 242 or Xylamide in the treatment of gastric and duodenal ulcers and of gastroduodenitis].
Bellomo A; Strobbia R; Manzoni A
Minerva Med; 1969 Mar; 60(23):1024-31. PubMed ID: 5781328
[No Abstract] [Full Text] [Related]
8. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
Sampietro R
Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329
[No Abstract] [Full Text] [Related]
9. [Proglumide (milide) in gastroduodenal therapeutics].
Geoffroy H; el-Haddad A; Coudoux P
Sem Hop Ther; 1974 Mar; 50(3):207-16. PubMed ID: 4612709
[No Abstract] [Full Text] [Related]
10. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
Mainoli S; Milvio C; Borellini D
Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
[No Abstract] [Full Text] [Related]
11. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
Gambini G; Grisler R
Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
[No Abstract] [Full Text] [Related]
12. [Study of the therapeutic activity of fentonium in gastroduodenal ulcer].
Tira PL
Minerva Chir; 1975 Mar; 30(6):311-22. PubMed ID: 1226242
[TBL] [Abstract][Full Text] [Related]
13. [Aluminium glycyrrhetate in the therapy of gastroduodenal peptic ulcer and of other gastroduodenal diseases].
Fontana G; Faggioli F
Minerva Med; 1969 Feb; 60(17):745-60. PubMed ID: 5776059
[No Abstract] [Full Text] [Related]
14. [Antisecretory therapeutic activity of Milid (xylamide, CR 242) in the treatment of gastroduodenal ulcer].
Giordano G; Comi L
Minerva Med; 1967 Oct; 58(86):3688-91. PubMed ID: 6061062
[No Abstract] [Full Text] [Related]
15. [The use of licorice juice in gastritis and gastroduodenal ulcer].
Angeleri C
Minerva Med; 1967 Apr; 58(27):1183-5. PubMed ID: 6024325
[No Abstract] [Full Text] [Related]
16. [Use of Xylamide (MILID) as an antisecretory-antigastrinic agent in acute pancreatitis].
Margnelli M; Zacco R; Velati GF
Minerva Gastroenterol; 1969; 15(4):229-34. PubMed ID: 5379889
[No Abstract] [Full Text] [Related]
17. [Treatment of gastroduodenal ulcer using bismoprimperan].
Arias Vallejo E; Sánchez García-Moreno
Rev Clin Esp; 1968 Nov; 111(4):423-30. PubMed ID: 5732975
[No Abstract] [Full Text] [Related]
18. [Clinical study on the use of phentonium in hypersecretive and ulcerative gastroduodenal diseases].
Azzollini F; Fichera G
Clin Ter; 1972 Nov; 63(3):259-67. PubMed ID: 4644530
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation, in gastritis and gastroduodenal ulcers of a new non-anticholinergic compound with protective and antisecretory activity].
Fantino M; Roccia L
Minerva Med; 1967 Oct; 58(86):3677-85. PubMed ID: 6061061
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with CR-242 (xylamide) in the treatment of ulcerative gastroduodenal diseases. Study of 30 cases].
Arias Vallejo E; Güemes Días F; Moreno Arranz B; Lozano Lozano C
Rev Clin Esp; 1969 May; 113(4):361-70. PubMed ID: 5801158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
